- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05684887
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon (DTECT)
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon (DTECT Cameroon)
According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing.
This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).
Study Overview
Detailed Description
The study's general objective is to assess the effectiveness, feasibility, acceptability, and cost associated with the addition of a Mamal Pro digital contact tracing module to the Mamal Pro app in improving COVID-19 contact tracing and testing in Littoral, Cameroon.
Specific objectives are:
Primary objective: To determine the effectiveness of the use of a Mamal Pro digital contact tracing module added to the Mamal Pro app in improving COVID-19 contact tracing and testing compared to the SOC as measured by:
- The number and proportion of reported contacts who received SARS-CoV-2 testing.
- The number and proportion of contacts who are successfully reached by phone by MOH district contact tracing unit.
- The number and proportion of contacts testing positive for SARS-CoV-2 infection.
- The time from SARS-CoV-2 infected index patient identification of contacts to communication with the contact by the district contact tracing unit.
Secondary objectives:
- To assess the feasibility and acceptability of the use of the Mamal Pro digital contact tracing module through structured interviews with MOH facility staff, district unit contract tracing teams, and individuals undergoing SARS-CoV-2 testing.
- To estimate the total cost of using the Mamal Pro contact tracing module for tracing SARS-CoV2 positive case contacts and cost per contact traced using the module.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Littoral
-
Douala, Littoral, Cameroon
- Bonanjo Integrated Health Center
-
Douala, Littoral, Cameroon
- Bonassama District COVID testing unit
-
Douala, Littoral, Cameroon
- Bonassama district hospital
-
Douala, Littoral, Cameroon
- Cité des palmiers District COVID testing unit
-
Douala, Littoral, Cameroon
- Cité des palmiers district hospital
-
Douala, Littoral, Cameroon
- CMA Bonamoussadi
-
Douala, Littoral, Cameroon
- CMA Nyala
-
Douala, Littoral, Cameroon
- CMA Soboum hospital
-
Douala, Littoral, Cameroon
- Deido District COVID testing unit
-
Douala, Littoral, Cameroon
- Deido district hospital
-
Douala, Littoral, Cameroon
- General Hospital Douala
-
Douala, Littoral, Cameroon
- Gynecological-Obstetric and Pediatric Hospital Douala (HGOPED)
-
Douala, Littoral, Cameroon
- Japoma District COVID testing unit
-
Douala, Littoral, Cameroon
- Laquintinie Hospital
-
Douala, Littoral, Cameroon
- Logbaba District COVID testing unit
-
Douala, Littoral, Cameroon
- Logbaba district hospital
-
Douala, Littoral, Cameroon
- Mbangue District COVID testing unit
-
Douala, Littoral, Cameroon
- Mboppi Baptist hospital
-
Douala, Littoral, Cameroon
- New Bell District COVID testing unit
-
Douala, Littoral, Cameroon
- New Bell district hospital
-
Douala, Littoral, Cameroon
- Nylon District COVID testing unit
-
Douala, Littoral, Cameroon
- Nylon district hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All contacts listed by individuals registered in the Mamal Pro app for testing, who test positive for SARS-CoV-2 in the selected health district testing units and health facilities in Cameroon.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of care model (SOC)
This model is based on the standard of care recommended by the Cameroon National COVID-19 response program.
|
|
|
Experimental: Intervention model (ITV)
Implementation of the contact tracing using a digitalized process (addition of the Mamal Pro digital contact tracing module to the Mamal Pro app).
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful contact tracing
Time Frame: 10 days
|
The primary outcome is the proportion of contacts declared by the index case who are successfully called by the district contact tracing unit and the proportion of contacts who receive SARS-CoV-2 testing, as per MOH standard testing procedures.
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contacts testing positive for SARS-CoV-2 infection.
Time Frame: 10 days
|
The proportion of contacts testing positive for SARS-CoV2 infection
|
10 days
|
|
Feasibility of the intervention model of contact tracing
Time Frame: 4 months
|
|
4 months
|
|
Acceptability intervention model of contact tracing by the index cases (negative and positive) and health care workers
Time Frame: 4 months
|
|
4 months
|
|
Cost of the intervention
Time Frame: 4 months
|
Cost estimates for using Mamal Pro digital contact tracing module to trace contacts, and cost per contact traced.
|
4 months
|
|
Timely communication with contacts
Time Frame: 4 months
|
Time (days) between receipt of contact list and contacts' call attempts
|
4 months
|
|
SMS sent
Time Frame: 4 months
|
Proportion of SMS delivered, (numerator: SMS sent, denominator: phone numbers)
|
4 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Boris Tchakounte Youngui, MD, MPH, Elizabeth Glaser Pediatric AIDS Foundation
- Principal Investigator: Godfrey Woelk, PhD, MCOMMH, Elizabeth Glaser Pediatric AIDS Foundation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EG0284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Digital based contact tracing
-
Johns Hopkins Bloomberg School of Public HealthPerinatal HIV Research Unit of the University of the Witswatersrand; Setshaba... and other collaboratorsCompleted
-
Ostergotland County Council, SwedenMedical Research Council of Southeast SwedenCompleted
-
International Islamic University MalaysiaCompletedOrthodontic | Cephalometric Analysis | CephalometryMalaysia
-
Children's Hospital of Fudan UniversityCompletedAttention Deficit Hyperactivity DisorderChina
-
Gazi UniversityThe Scientific and Technological Research Council of TurkeyRecruiting
-
Afra ÇALIKCompletedHemodialysis | Anxiety | Adherence | Game-Based LearningTurkey (Türkiye)
-
Alcon ResearchCompleted
-
George Mason UniversityCompleted
-
Stockholm UniversityCompletedProcrastinationSweden